BP
CLB icon

Ballentine Partners’s Core Laboratories CLB Stock Holding History

Ballentine Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,062
Closed -$174K – 926
2024
Q4 		$174K Sell
10,062
-39
-0.4% -$753 ﹤0.01% 800
2024
Q3 		$187K Sell
10,101
-29
-0.3% -$582 ﹤0.01% 757
2024
Q2 		$206K Buy
+10,130
New +$179K ﹤0.01% 687
2024
Q1 		– Sell
-16,334
Closed -$288K – 744
2023
Q4 		$288K Buy
+16,334
New +$329K 0.01% 512
2017
Q1 		– Sell
-2,461
Closed -$282K – 256
2016
Q4 		$282K Buy
2,461
+556
+29% +$61.6K 0.02% 155
2016
Q3 		$214K Hold
1,905
– – 0.02% 170
2016
Q2 		$237K Sell
1,905
-100
-5% -$12.1K 0.02% 177
2016
Q1 		$225K Buy
+2,005
New +$208K 0.02% 182

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ballentine Partners's CLB Position: Q1 2025 in Review

Ballentine Partners sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 10,062 shares — an estimated $174K sold.

Ballentine Partners first reported a position in CLB in Q1 2016 and held it in 8 quarters. The position peaked at $288K in Q4 2023. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Ballentine Partners reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Ballentine Partners sold 10,062 Core Laboratories shares in Q1 2025, an estimated $174K.
  • Ballentine Partners first reported a position in Core Laboratories in Q1 2016 and held it in 8 quarters.
  • Ballentine Partners's Core Laboratories position peaked at $288K in Q4 2023.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Ballentine Partners's 13F filing for Q1 2025, filed 1 May 2025.